- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07736209
Effects of Heavy Back-Squat PAPE on Jump and Repeated Sprint Performance in Trained Soccer Players
29 juillet 2026 mis à jour par: Abdullah Demirli, Istanbul University - Cerrahpasa
The PAPE Paradox During Prolonged Repeated Sprint Performance: Acute Heavy Back-Squat Potentiates Vertical Jump and Early Sprint Performance But Impairs Overall Output-A Randomized Crossover Trial in Trained Soccer Players
This study examined whether performing heavy back squats before exercise affects jumping ability and repeated sprint performance in trained soccer players.
Twenty male university soccer players completed two testing sessions in a randomized crossover design.
In one session, participants performed a standardized warm-up only.
In the other session, they performed the same warm-up followed by three sets of three back-squat repetitions at 90% of their one-repetition maximum.
The two sessions were separated by one week.
After each condition, participants completed a countermovement jump test and an 18 × 40-meter repeated sprint test.
The study aimed to determine whether the heavy back-squat activity improves early explosive performance and whether it increases fatigue during prolonged repeated sprint exercise.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
20
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Istanbul
-
Istanbul, Istanbul, Turquie (Türkiye), 34320
- İstanbul University Cerrahpaşa
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- Male soccer players aged 20-23 years.
- Currently competing in the top division of a university soccer league.
- A minimum of three years of regular soccer training experience.
- Free from long-term musculoskeletal injury during the previous six months.
- Willing and able to complete all familiarization, strength-testing, and experimental sessions.
- Provision of written informed consent.
Exclusion Criteria:
- A musculoskeletal injury resulting in an absence from training or competition for 21 days or longer during the previous six months.
- Use of medications or nutritional or ergogenic supplements that could affect exercise performance.
- Any health or physical condition preventing safe participation in heavy back-squat, countermovement jump, or repeated sprint testing.
- Failure to complete both experimental conditions.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Control-PAPE Sequence
Participants first completed the Control condition, consisting of a standardized warm-up without an additional conditioning activity.
After a one-week washout period, participants completed the PAPE condition, consisting of the same standardized warm-up followed by three sets of three back-squat repetitions at 90% of one-repetition maximum, with 3 minutes of passive recovery between sets.
Countermovement jump and repeated sprint performance were assessed after each condition.
|
Participants completed a standardized warm-up followed by a heavy back-squat conditioning activity consisting of three sets of three repetitions at 90% of one-repetition maximum.
Three minutes of passive recovery were provided between sets.
Countermovement jump performance was assessed approximately 4.5-5 minutes after the final squat set, immediately before the repeated sprint test.
Participants completed a standardized warm-up consisting of 5 minutes of jogging, followed by 10 bodyweight squats, 10 lunges, and 10 lateral shuffles.
No additional conditioning activity was performed.
After approximately 5 minutes of passive recovery, countermovement jump performance was assessed immediately before the repeated sprint test.
|
|
Expérimental: PAPE-Control Sequence
Participants first completed the PAPE condition, consisting of a standardized warm-up followed by three sets of three back-squat repetitions at 90% of one-repetition maximum, with 3 minutes of passive recovery between sets.
After a one-week washout period, participants completed the Control condition, consisting of the same standardized warm-up without an additional conditioning activity.
Countermovement jump and repeated sprint performance were assessed after each condition.
|
Participants completed a standardized warm-up followed by a heavy back-squat conditioning activity consisting of three sets of three repetitions at 90% of one-repetition maximum.
Three minutes of passive recovery were provided between sets.
Countermovement jump performance was assessed approximately 4.5-5 minutes after the final squat set, immediately before the repeated sprint test.
Participants completed a standardized warm-up consisting of 5 minutes of jogging, followed by 10 bodyweight squats, 10 lunges, and 10 lateral shuffles.
No additional conditioning activity was performed.
After approximately 5 minutes of passive recovery, countermovement jump performance was assessed immediately before the repeated sprint test.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Repeated Sprint Performance Decrement
Délai: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Percentage decline in repeated sprint performance calculated from sprint times recorded during an 18 × 40-meter shuttle sprint test.
The protocol consisted of three sets of six 40-meter shuttle sprints, with 20 seconds of passive recovery between sprints and 4 minutes of passive recovery between sets.
Lower percentage values indicate better maintenance of sprint performance and less fatigue.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Countermovement Jump Height
Délai: At approximately 5 minutes after the assigned condition, within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Maximum countermovement jump height measured in centimeters using the Optojump Next optical measurement system.
Participants performed three maximal countermovement jump trials with their hands positioned on their hips and 60 seconds of passive recovery between trials.
The highest jump height was used for analysis.
Higher values indicate better jump performance.
|
At approximately 5 minutes after the assigned condition, within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Mean Repeated Sprint Time
Délai: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Mean sprint time, measured in seconds, calculated across all 18 repetitions of the 40-meter shuttle sprint test.
Sprint times were recorded using a photocell timing system.
Lower values indicate better repeated sprint performance.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Best Sprint Time
Délai: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
The fastest sprint time, measured in seconds, recorded among the 18 repetitions of the 40-meter shuttle sprint test using a photocell timing system.
Lower values indicate better sprint performance.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Worst Sprint Time
Délai: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
The slowest sprint time, measured in seconds, recorded among the 18 repetitions of the 40-meter shuttle sprint test using a photocell timing system.
Lower values indicate better sprint performance.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Sprint Time Across Individual Repetitions
Délai: During each repetition of the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period
|
Sprint time, measured in seconds, for each of the 18 individual 40-meter shuttle sprint repetitions.
Sprint-by-sprint values were used to evaluate changes in performance during the early repetitions (sprints 1-3), middle repetitions (sprints 4-8), and later repetitions (sprints 9-18).
Lower values indicate faster sprint performance.
|
During each repetition of the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
20 décembre 2025
Achèvement primaire (Réel)
15 février 2026
Achèvement de l'étude (Réel)
15 février 2026
Dates d'inscription aux études
Première soumission
26 juillet 2026
Première soumission répondant aux critères de contrôle qualité
29 juillet 2026
Première publication (Réel)
30 juillet 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
30 juillet 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
29 juillet 2026
Dernière vérification
1 juillet 2026
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- PAPE-RSA-2025-01
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .